BTK-IN-31 (Compound 2) is a selective, non-covalently reversible, and blood-brain barrier (BBB) permeable Btk inhibitor. BTK-IN-31 has research potential in immune disorders, cancer, cardiovascular disease, viral infections, inflammation, metabolic/endocrine dysfunction, and neurological disorders[1].
Molecular Weight:
434.46
CAS Number:
[2662512-02-7]
Formula:
C24H23FN4O3
Target:
Btk
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted